These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9118358)

  • 1. Relationship between sympathoadrenal and pituitary-adrenal response during colorectal distention in the presence of corticotropin-releasing hormone in patients with irritable bowel syndrome and healthy controls.
    Tanaka Y; Kanazawa M; Kano M; Tashiro M; Fukudo S
    PLoS One; 2018; 13(7):e0199698. PubMed ID: 29979696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge.
    Linthorst AC; Flachskamm C; Hopkins SJ; Hoadley ME; Labeur MS; Holsboer F; Reul JM
    J Neurosci; 1997 Jun; 17(11):4448-60. PubMed ID: 9151762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin releasing hormone antagonist does not prevent adrenalectomy-induced apoptosis in the dentate gyrus of the rat hippocampus.
    Gerth A; Hatalski CG; Avishai-Eliner S; Baram TZ
    Stress; 1998 Jul; 2(3):159-69. PubMed ID: 9787264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.
    Wong ML; Kling MA; Munson PJ; Listwak S; Licinio J; Prolo P; Karp B; McCutcheon IE; Geracioti TD; DeBellis MD; Rice KC; Goldstein DS; Veldhuis JD; Chrousos GP; Oldfield EH; McCann SM; Gold PW
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):325-30. PubMed ID: 10618417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of maternal behaviour by central infusion of corticotrophin-releasing hormone in marmoset monkeys.
    Saltzman W; Boettcher CA; Post JL; Abbott DH
    J Neuroendocrinol; 2011 Nov; 23(11):1139-48. PubMed ID: 21554432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-Releasing Hormone: Biology and Therapeutic Opportunities.
    Caruso A; Gaetano A; Scaccianoce S
    Biology (Basel); 2022 Dec; 11(12):. PubMed ID: 36552294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond depression and anxiety; a systematic review about the role of corticotropin-releasing hormone antagonists in diseases of the pelvic and abdominal organs.
    Pagán-Busigó JE; López-Carrasquillo J; Appleyard CB; Torres-Reverón A
    PLoS One; 2022; 17(3):e0264909. PubMed ID: 35275963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling epileptic spasms during infancy: Are we heading for the treatment yet?
    Velíšek L; Velíšková J
    Pharmacol Ther; 2020 Aug; 212():107578. PubMed ID: 32417271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infantile spasms: hypothesis-driven therapy and pilot human infant experiments using corticotropin-releasing hormone receptor antagonists.
    Baram TZ; Mitchell WG; Brunson K; Haden E
    Dev Neurosci; 1999 Nov; 21(3-5):281-9. PubMed ID: 10575251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fetal ethanol exposure on pituitary-adrenal sensitivity to secretagogues.
    Osborn JA; Yu C; Stelzl GE; Weinberg J
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1110-9. PubMed ID: 10924017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep and the hypothalamo-pituitary-adrenocortical system.
    Steiger A
    Sleep Med Rev; 2002 Apr; 6(2):125-38. PubMed ID: 12531148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone secretagogues as corticotrophin-releasing factors.
    Ghigo E; Arvat E; Camanni F
    Growth Horm IGF Res; 1998 Apr; 8 Suppl B():145-8. PubMed ID: 10990151
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of pituitary-adrenal secretion by a corticotropin releasing hormone antagonist in humans.
    Baram TZ; Mitchell WG; Haden E
    Mol Psychiatry; 1996 Sep; 1(4):320-4. PubMed ID: 9118358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys.
    Broadbear JH; Winger G; Rivier JE; Rice KC; Woods JH
    Neuropsychopharmacology; 2004 Jun; 29(6):1112-21. PubMed ID: 14997174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
    Tanaka T; Hibi I; Shimizu N; Imura H; Tanaka K; Fukata J; Fujieda K; Ichimura T; Kuribayashi T; Ito K
    Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.